The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)
Official Title: A Randomized, Blind, Parallel Controlled, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Pembrolizumab Injection as a First-line Treatment on Patient With Advanced NSCLC.
Study ID: NCT04964479
Brief Summary: A clinical study to evaluate the efficacy and safety of TQB2450 injection combined with Anlotinib Hydrochloride capsules versus K drug as a first-line treatment of advanced non-small cell lung cancer.A total of 375 subjects will be enrolled.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
China-Japan Friendship Hospital, Beijing, Beijing, China
Beijing Chest Hospital, Capital Medical University, Beijing, Beijing, China
Peking University Third Hospital, Beijing, Beijing, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Affiliated Hospital of Guangdong Medical University, Zhangjiang, Guangdong, China
Shanghai Chest Hospital, Shanghai, Shanghai, China
The Ninth Affiliated People's Hospital of Shanghai Jiao Tong University, School of Medicine, Shanghai, Shanghai, China
Tianjin Cancer Hospital, Tianjin, Tianjin, China
General Hospital of Tianjin Medical University, Tianjin, Tianjin, China
Tianjin Chest Hospital, Tianjin, Tianjin, China
Affiliated Tumor Hospital of Chongqing University, Chongqing, , China
Three Gorges Hospital of Chongqing University, Chongqing, , China
Southern Hospital of Southern Medical University, Guangzhou, , China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, , China
Zhujiang Hospital of Southern Medical University, Guangzhou, , China
Zhujiang Hospital of Southern Medical University, Guangzhou, , China
The Fifth Central Hospital of Tianjin, Tianjin, , China